( August 12, 2026, 8:59 AM EDT) -- WASHINGTON, D.C. — Abbott Laboratories urges the U.S. Judicial Panel on Multidistrict Litigation (JPMDL) to reject a renewed effort by individuals who allege that they were injured by defective spinal cord stimulators (SCS) to centralize all pending cases against the manufacturer, arguing that the cases involve different devices, injuries and representations and lack common factual questions warranting an MDL; the panel previously created an MDL that included only cases against Boston Scientific Corp....